Copper sulfate-induced hemolytic anemia. Inhibition of glucose-6-phosphate dehydrogenase and other possible etiologic mechanisms.
D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D003300:Copper / Q000009:adverse effects*; D004112:Dimercaprol / Q000627:therapeutic use; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors*; D005955:Glucosephosphate Dehydrogenase Deficiency; D005978:Glutathione / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects; D006366:Heinz Bodies; D006454:Hemoglobins; D006801:Humans; D009243:NAD / Q000378:metabolism; D009582:Nitrofurantoin / Q000627:therapeutic use; D010084:Oxidation-Reduction; D013431:Sulfates
D006454:Hemoglobins; D013431:Sulfates; D004112:Dimercaprol; D009243:NAD; D003300:Copper; D009582:Nitrofurantoin; D005954:Glucosephosphate Dehydrogenase; D005978:Glutathione